摘要
目的 分析血府逐瘀汤加减对肝硬化腹水患者的临床疗效及安全性。方法 采用回顾性研究方法，选取我院2023年1月至2025年12月期间收治的肝硬化腹水患者86例，根据治疗方案分为对照组（西医治疗）和观察组（西医联合血府逐瘀汤加减治疗）。结果 治疗后观察组的（丙氨酸氨基转移酶）ALT、（天门冬氨酸氨基转移酶）AST、（总胆红素）TBil水平分别为明显低于对照组，ALB更高，腹水深度更低，24h尿量更多，临床有效率更高（P<0.05）。结论 血府逐瘀汤加减可能通过改善肝脏合成功能与减轻门脉高压的双重路径缓解腹水。
关键词： 血府逐瘀汤；肝硬化腹水；肝功能；中医药
Abstract
Objective To analyze the clinical efficacy and safety of modified Xuefu Zhuyu Tang in patients with liver cirrhosis ascites. Methods A retrospective study was conducted on 86 patients with liver cirrhosis ascites admitted to our hospital from January 2023 to December 2025. According to the treatment plan, they were divided into a control group (treated with Western medicine) and an observation group (treated with Western medicine combined with modified Xuefu Zhuyu Tang). Results After treatment, the levels of ALT, AST, and TBil in the observation group were significantly lower than those in the control group, with higher ALB, lower ascites depth, more 24-hour urine output, and higher clinical efficacy rate (P<0.05). Conclusion The modification of Xuefu Zhuyu Tang may alleviate ascites through a dual pathway of improving liver synthesis function and reducing portal hypertension.
Key words： Xuefu Zhuyu Tang; Cirrhotic ascites; Liver function; Traditional Chinese medicine
参考文献 References
[1] 朱欧鸰,张艳彬,王立业,等.清热利湿逐水加减方治疗湿热蕴结证肝硬化腹水患者的临床疗效及安全性[J].世界中西医结合杂志,2024,19(11):2251-2256.
[2] 刘祎,杨漾,苏畅,等.基于ACSL4信号通路探讨血府逐瘀汤干预冠心病血瘀证大鼠铁死亡的作用机制[J].中国实验方剂学杂志,2025,31(06):27-38.
[3] 徐小元,丁惠国,李文刚,等.肝硬化腹水及相关并发症的诊疗指南[J].临床肝胆病杂志,2017,33(10):1847-1863.
[4] 梁茂新,高天舒.《中药新药临床研究指导原则》脏腑诸证考察与分析[J].中国中医基础医学杂志,2008,(05):330-331+342.
[5] 林勇,曾欣,胡平方.中国肝硬化临床诊治共识意见[J].临床肝胆病杂志,2023,39(09):2057-2073.
[6] 石俊豪,赵晨露,李亚东,等.中药穴位贴敷治疗肝硬化腹水研究进展[J].中医学报,2023,38(07):1459-1467.
[7] 刘巍,韩涛.血府逐瘀汤加减对乙肝肝硬化失代偿期肝纤维化及炎性因子的影响[J].实用药物与临床,2021,24(09): 821-825.
[8] 吴阳,董汾,王克穷,等.血府逐瘀汤联合恩替卡韦治疗瘀血阻络型乙型肝炎肝硬化代偿期患者的临床效果[J].广西医学,2024,46(09):1366-1372.